Sai Parenterals Shareholding Pattern & Promoter Holding
Pharmaceuticals & Biotechnology · Latest pattern: Sep 2026
As of Sep 2026, promoters hold 51.16% of Sai Parenterals, FIIs hold 2.85%, DIIs hold 7.83% and the public holds 38.16%. Promoter holding was unchanged from Jun 2026.
Get an alert when Sai Parenterals reports results or its shareholding changes. Free account.
Promoters
51.16%
unchanged QoQ
FIIs
2.85%
−1.18 pp QoQ
DIIs
7.83%
−0.69 pp QoQ
Public
38.16%
+1.87 pp QoQ
Sai Parenterals shareholding, quarter by quarter
| Quarter | Promoters | FIIs | DIIs | Public | Shareholders |
|---|---|---|---|---|---|
| Sep 2026 | 51.16% | 2.85% | 7.83% | 38.16% | 13,645 |
| Jun 2026 | 51.16% | 4.03% | 8.52% | 36.29% | 9,312 |
| Mar 2026 | 51.16% | 5.73% | 12.86% | 30.25% | 7,687 |
Promoters · FIIs (foreign institutions) · DIIs (domestic institutions) · Public (retail & others). Percentages of total shares, from the quarterly pattern filed with the exchanges.
Value of the promoter stake
At a market capitalisation of ₹2.20k cr, the promoter group's 51.16% stake is worth ₹1.12k cr. A promoter group is usually a family, trust or holding company; this figure covers only this listed company and is not anyone's net worth.
Promoter holding in Pharmaceuticals & Biotechnology peers
Sai Parenterals shareholding: common questions
What is the promoter holding in Sai Parenterals?
Promoters hold 51.16% of Sai Parenterals as of Sep 2026. Their stake was unchanged from Jun 2026.
How much do FIIs hold in Sai Parenterals?
Foreign institutional investors (FIIs) held 2.85% of Sai Parenterals in Sep 2026, −1.18 pp versus Jun 2026.
How much do mutual funds and other DIIs hold in Sai Parenterals?
Domestic institutional investors (DIIs), which include mutual funds and insurers, held 7.83% of Sai Parenterals in Sep 2026, −0.69 pp versus Jun 2026.
Is the promoter holding in Sai Parenterals pledged?
The latest disclosed shareholding pattern shows no pledged promoter shares in Sai Parenterals.
How many shareholders does Sai Parenterals have?
Sai Parenterals had 13,645 shareholders in Sep 2026, compared with 9,312 in Jun 2026.